Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,597 | -358 | 622 | -9,516 | -7,850 |
| Depreciation Amortization | 5,431 | 3,582 | 1,791 | 7,855 | 5,824 |
| Income taxes - deferred | 92 | 86 | -55 | -414 | -160 |
| Accounts receivable | 1,751 | -68 | -923 | 4,780 | 6,060 |
| Accounts payable and accrued liabilities | -298 | -270 | -150 | -1,399 | -2,379 |
| Other Working Capital | 2,211 | -1,379 | -1,296 | 2,716 | 1,158 |
| Other Operating Activity | 2,135 | 3,771 | 1,823 | -2,870 | -4,180 |
| Operating Cash Flow | $9,725 | $5,364 | $1,812 | $1,152 | $-1,527 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -446 | -229 | 288 | -1,590 | -1,355 |
| Purchase Sale Intangibles | -292 | -108 | N/A | N/A | N/A |
| Other Investing Activity | -292 | -108 | 0 | 0 | 0 |
| Investing Cash Flow | $-738 | $-337 | $288 | $-1,590 | $-1,355 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,500 | 2,500 | 1,500 | 7,800 | 7,800 |
| Debt Repayment | -8,450 | -8,041 | -4,341 | -9,586 | -7,086 |
| Common Stock Issued | 724 | 724 | 104 | 577 | 346 |
| Other Financing Activity | -3,792 | -451 | -156 | -1,628 | -1,167 |
| Financing Cash Flow | $-8,018 | $-5,268 | $-2,893 | $-2,837 | $-107 |
| Exchange Rate Effect | -137 | 57 | 74 | -38 | 312 |
| Beginning Cash Position | 4,508 | 4,508 | 4,508 | 7,821 | 7,821 |
| End Cash Position | 5,340 | 4,324 | 3,789 | 4,508 | 5,144 |
| Net Cash Flow | $832 | $-184 | $-719 | $-3,313 | $-2,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,725 | 5,364 | 1,812 | 1,152 | -1,527 |
| Capital Expenditure | -958 | -741 | -224 | -1,590 | -1,355 |
| Free Cash Flow | 8,767 | 4,623 | 1,588 | -438 | -2,882 |